Literature DB >> 3923058

Evaluation of Bactigen latex agglutination and Phadebact coagglutination for detection of bacterial antigens in cerebrospinal fluid.

Y M Coovadia, K K Naidu.   

Abstract

The Bactigen latex agglutination and Phadebact coagglutination tests were evaluated for their ability to detect bacterial antigens of Haemophilus influenzae type b, Streptococcus pneumoniae (83 serotypes) and Neisseria meningitidis groups A, B, C, and Y in 214 samples of cerebrospinal fluid (CSF). Bactigen latex agglutination was more sensitive than Phadebact coagglutination: it detected 87% (59/68) of culture positive CSF specimens, whereas Phadebact detected 72% (52/72). Bactigen detected all cases of meningitis caused by S pneumoniae and H influenzae. Of the 19 specimens that were positive for N meningitidis, 74% were detected by Phadebact and only 53% by Bactigen. Gram stain results were positive for 85% of all specimens positive on culture. Bactigen was slightly more specific (97%) than Phadebact (96%). Bactigen, however, showed less specificity (81%) than Phadebact (94%) on 31 CSF specimens that were culture positive for organisms other than the test organisms. These included two CSF specimens from patients with tuberculous meningitis which gave false positive results for S pneumoniae with the Bactigen reagents. No false positive results were obtained on 104 culture negative CSF samples. Bactigen latex agglutination was superior to Phadebact coagglutination and Gram stain for the detection of S pneumoniae and H influenzae in CSF specimens from patients with bacteriologically proved meningitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923058      PMCID: PMC499209          DOI: 10.1136/jcp.38.5.561

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Determination of bacterial meningitis: a retrospective study of 80 cerebrospinal fluid specimens evaluated by four in vitro methods.

Authors:  B L Wasilauskas; K D Hampton
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

2.  Comparative evaluation of three commercial products and counterimmunoelectrophoresis for the detection of antigens in cerebrospinal fluid.

Authors:  R C Tilton; F Dias; R W Ryan
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

3.  Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis.

Authors:  D L Drow; D F Welch; D Hensel; K Eisenach; E Long; M Slifkin
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

4.  Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid.

Authors:  D F Welch; D Hensel
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

5.  Comparative laboratory evaluation of three antigen detection methods for diagnosis of Haemophilus influenzae type b disease.

Authors:  M J Marcon; A C Hamoudi; H J Cannon
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

6.  Counterimmunoelectrophoresis in the diagnosis of bacterial meningitis.

Authors:  H Colding; I Lind
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

7.  Diagnosis of bacterial meningitis by gas-liquid chromatography. II. Analysis of spinal fluid.

Authors:  F M LaForce; J L Brice; T G Tornabene
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

  7 in total
  3 in total

1.  Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae.

Authors:  H Russell; J A Tharpe; D E Wells; E H White; J E Johnson
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 2.  Laboratory diagnosis of bacterial meningitis.

Authors:  L D Gray; D P Fedorko
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Lumbar punctures: use and diagnostic efficiency in emergency medical departments.

Authors:  Bilal Majed; Hélène Zephir; Valérie Pichonnier-Cassagne; Yazdan Yazdanpanah; Philippe Lestavel; Pierre Valette; Patrick Vermersch
Journal:  Int J Emerg Med       Date:  2009-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.